Apellis Pharmaceuticals Inc (APLS)
41.30
-0.70
(-1.67%)
USD |
NASDAQ |
May 17, 16:00
41.30
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals EPS Diluted (Quarterly): -0.54 for March 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.54 |
| December 31, 2023 | -0.73 |
| September 30, 2023 | -1.17 |
| June 30, 2023 | -1.02 |
| March 31, 2023 | -1.56 |
| December 31, 2022 | -1.50 |
| September 30, 2022 | -1.75 |
| June 30, 2022 | -1.46 |
| March 31, 2022 | -1.42 |
| December 31, 2021 | -1.53 |
| September 30, 2021 | -2.28 |
| June 30, 2021 | -2.72 |
| March 31, 2021 | -2.32 |
| December 31, 2020 | 1.06 |
| September 30, 2020 | -1.79 |
| June 30, 2020 | -1.57 |
| March 31, 2020 | -2.29 |
| December 31, 2019 | -2.11 |
| Date | Value |
|---|---|
| September 30, 2019 | -1.10 |
| June 30, 2019 | -1.12 |
| March 31, 2019 | -0.87 |
| December 31, 2018 | -0.65 |
| September 30, 2018 | -0.64 |
| June 30, 2018 | -0.61 |
| March 31, 2018 | -0.43 |
| December 31, 2017 | -0.3627 |
| September 30, 2017 | -0.3003 |
| June 30, 2017 | -0.6702 |
| March 31, 2017 | -0.5002 |
| December 31, 2016 | -0.3659 |
| September 30, 2016 | -0.3985 |
| December 31, 2015 | -0.4541 |
| September 30, 2015 | -1.724 |
| December 31, 2014 | -0.1486 |
| September 30, 2014 | -0.1365 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-2.72
Minimum
Jun 2021
1.06
Maximum
Dec 2020
-1.446
Average
-1.515
Median
EPS Diluted (Quarterly) Benchmarks
| Inspire Medical Systems Inc | -0.34 |
| Sarepta Therapeutics Inc | 0.37 |
| Blueprint Medicines Corp | 1.40 |
| Alnylam Pharmaceuticals Inc | -0.52 |
| Cytokinetics Inc | -1.33 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -66.42M |
| Revenue (Quarterly) | 172.32M |
| Total Expenses (Quarterly) | 234.42M |
| Enterprise Value | 4.781B |
| Gross Profit Margin (Quarterly) | 88.27% |
| Profit Margin (Quarterly) | -38.55% |
| Earnings Yield | -8.38% |
| Normalized Earnings Yield | -8.376 |